Royalty Pharma
Kristen Overly is a professional with extensive experience in the life sciences sector, currently serving as an Associate in Research and Investments at Royalty Pharma since September 2022. Prior to this role, Kristen held the position of Senior Analyst at Back Bay Life Science Advisors, where responsibilities included providing integrated strategy consulting and investment banking services tailored to the life sciences industry. Additional experience includes serving as Director/Advisor for the MIT Alumni Life Science Angels of Boston, an organization connecting MIT-alumni angel investors with biotech and healthcare startups, as well as roles at J.P. Morgan, Remora Therapeutics, Lifespans, Ltd., and as an Undergraduate Researcher at the Massachusetts Institute of Technology. Kristen earned a Bachelor's Degree in Biological Engineering and Chinese from the Massachusetts Institute of Technology in 2020, following a foundational education at Phillips Academy Andover.
This person is not in any teams
Royalty Pharma
3 followers
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals, and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies.